TCL Archive Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines. March 31, 2000
TCL Archive NCI Oks Expanded Breast Cancer Low Fat Prevention Trial, Plans To End Stage 2 Adjuvant Low Fat Study January 31, 1986